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Febrile diseaseSummary Objectives: The diagnosis of typhoid fever is a challenge. Aiming to develop a
typhoid diagnostic we measured antibody responses against Salmonella Typhi (S. Typhi) pro-
tein antigens and the Vi polysaccharide in a cohort of Bangladeshi febrile patients.
Methods: IgM against 12 purified antigens and the Vi polysaccharide was measured by ELISA in
plasma from patients with confirmed typhoid fever (n Z 32), other confirmed infections
(n Z 17), and healthy controls (n Z 40). ELISAs with the most specific antigens were per-
formed on plasma from 243 patients with undiagnosed febrile disease.
Results: IgM against the S. Typhi protein antigens correlated with each other (rho > 0.8), but
not against Vi (rho < 0.6). Typhoid patients exhibited higher IgM against 11/12 protein antigens
and Vi than healthy controls and those with other infections. Vi, PilL, and CdtB exhibited the
greatest sensitivity and specificity. Specificity and sensitivity was improved when Vi was com-
bined with a protein antigen, generating sensitivities and specificities of 0.80 and >0.85,
respectively. Applying a dynamic cut-off to patients with undiagnosed febrile disease sug-
gested that 34e58% had an IgM response indicative of typhoid.
Conclusions: We evaluated the diagnostic potential of several S. Typhi antigens; our assays
give good sensitivity and specificity, but require further assessment in differing patient popu-
lations.
ª 2017 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).Introduction
Enteric (typhoid) fever is a systemic infection caused by
Salmonella enterica serovars Typhi (S. Typhi) and Paratyphi
A (S. Paratyphi A).1,2 There are an estimated 12 million
cases of typhoid (S. Typhi only) worldwide annually leading
to approximately 120,000 deaths.3,4 The organisms are
transmitted via the fecal-oral route and the disease re-
mains common in low/middle income countries in South/
Southeast Asia and sub-Saharan Africa.5 Despite S. Paraty-
phi A being an emergent cause of enteric fever in parts of
South and Southeast Asia,6 S. Typhi remains the most
commonly reported etiological agent of enteric fever in
Asia and Africa.
Typhoid occurs only in humans, making it a disease that
can technically be eradicated.7 Indeed, typhoid has all but
been eliminated from several countries in Southeast Asia
where it was the most common cause of hospitalized febrile
disease 20e30 years ago.8,9 Elimination in these areas is
generally attributed to extensive improvements in sanita-
tion rather than widespread immunization schemes. The
lack of data regarding the long-term impact of mass immu-
nization for typhoid and the performance of licensed vac-
cines have hindered immunization as a sustainable
typhoid control and elimination strategy. Future consider-
ations for rational control measures for typhoid will rely
on more accurately assessing disease burden, which re-
quires a reliable diagnostic approach.10All commonly used typhoid diagnostics perform poorly
and are a roadblock for disease control efforts.11,12
Currently, the only reliable method for the identification
of febrile individuals with typhoid is the culture of a caus-
ative organism from a biological specimen.12,13 However,
this procedure is restricted to laboratories with adequate
equipment and microbiology training, and the method has
a limited sensitivity due to low concentrations of organisms
in the peripheral circulation.14e16 Low bacterial loads have
a similar impact on other methods that rely on detecting
the presence of the infecting organisms, such as antigen
detection or nucleic acid amplification. These methods
are often reported to be highly sensitive, but have unreal-
istic performances; pre-treatment with antimicrobials is
likely to compound this issue further.11,15 New typhoid diag-
nostics are a necessity and various approaches have been
evaluated, including measurement of innate immune re-
sponses,17,18 antibody in lymphocyte supernatants,19,20
and the identification of metabolomic signatures.21 Howev-
er, these advances are still restricted to research labora-
tories and are not yet ready to be developed into simple,
rapid diagnostic tests (RDTs).
We previously exploited a protein microarray to identify
a multitude of immunogenic S. Typhi protein antigens to
which an antibody response was generated during the early
stages of typhoid.22 With the aim of validating antigens that
could be used in a diagnostic assay we expressed and puri-
fied several of these potentially serodiagnostic S. Typhi
106 N. Tran Vu Thieu et al.antigens and investigated their diagnostic performance in a
cohort of febrile Bangladeshi patients.
Materials and methods
Ethical approval
The study was conducted according to the principles
expressed in the Declaration of Helsinki. The Bangladesh
National Research Ethical Committee (BMRC/NREC/2010-
2013/1543), the Chittagong Medical College Hospital
Ethical Committee, the Oxford Tropical Research Ethics
Committee (OXTREC 53-09) gave ethical approval for the
study. Informed written or thumbprint consent was taken
from the subject, their parent or caretaker for all
enrollees.
Study site, population and study design
The site and recruitment for this study has been descried
previously.23 Briefly, Chittagong Medical College Hospital is
a 1000-bed hospital serving Chittagong and the surrounding
province. Adults and children (>6 months) consecutively
admitted from January to June 2012 to the adult and pedi-
atric wards at CMCH with an axillary temperature of 38 C
up to 48 h after admission and history of fever for <2 weeks
were eligible for the study.
Here the gold standards for typhoid diagnosis were and
blood culture and PCR amplification from blood using a
previously described method.15 Blood (5e12 mL for adults
and 1e2 mL for children) was cultured using Bact/Alert-
FA and PF blood culture bottles, bottles were incubated
in the Bact/Alert automated system (Biomerieux, France)
for five days. The patient demographics and diagnostic
testing results for this study are reported elsewhere.23
For the purposes of this investigation plasma samples
from 40 healthy adult control subjects (hospital staff atTable 1 Salmonella Typhi antigens expressed in this study for
Gene ID
numbera
Isotype detected
using arrayb
Gene
name
Amino acid
identity S.
Typhi CT18/S.
Paratyphi A
AKU_12601
A
STY0452 IgM yajI 163/165 (98%) P
STY0796 IgM ybgF 260/262 (99%) P
STY1086 IgM e 187/187 (100%) P
STY1372 IgM pspB 74/74 (100%) P
STY1612 IgM e Absent P
STY4539 IgM pilL Absent P
STY1522 IgG e 292/296 (99%) P
STY1703 IgG ssaP 123/124 (99%) P
STY1767 IgG nlpC 48/140 (34%) P
STY1886 IgG cdtB 268/269 (99%) C
STY3208 IgG e 277/279 (99%) H
STY4190 IgG yhjJ 190/192 (99.0%) P
a Parkhill et al. 2001.48
b Liang et al. 2013.22the study site), 32 cases of confirmed typhoid (16 cases
confirmed by blood culture, 13 cases confirmed by PCR
and three cases confirmed by both blood culture and
PCR), 17 cases from patients with confirmed febrile dis-
eases other than enteric fever (Staphylococcus aureus (2),
Streptococcus pneumoniae (1), Streptococcus acidomini-
mus (1), Enterococcus gallinarum (1), Escherichia coli (2),
Klebsiella pneumoniae (1), Enterobacter cloacae (2), Aci-
netobacter spp. (1), Burkholderia cepacia (3), dengue (2),
R. typhi (2) and O. tsutsugamushi (1)) and 243 febrile pa-
tients with undiagnosed febrile disease were subjected to
serological assays.PCR amplification, gene expression and protein
purification
We selected 18 S. Typhi antigens that gave a differential
serodiagnostic signal using protein microarray screening
for further expression and purification (Table S1). The cod-
ing sequences of the selected genes, excluding trans-
membrane domains were PCR amplified from CT18 genomic
DNA and cloned into the 50 NcoI and 30NotI restriction sites
of pET28b(þ) vector (Novagen, UK) for further His-Tag puri-
fication. E. coli DH5a were transformed with the plasmid
constructs for stable storage and E. coli BL21(DE3)pLysS
(Promega, WI, USA) were used for expression and purifica-
tion (Table S1).
For protein expression, the E. coli BL21(DE3)pLysS
strains harboring unique plasmid constructs (pEK90-
pEK109) containing the genes of interest were inoculated
into LB broth containing 100 mg/L kanamycin (Sigma, MO,
USA), and incubated at 37 C overnight. Overnight cultures
were diluted (1:100) into LB broth and incubated at 37 C
with agitation until optical density (OD600) of 0.5. Expres-
sion of the exogenous proteins was induced by the addition
of isopropyl-b-D-thiogalactoside (IPTG) (SigmaeAldrich,
UK), to a final concentration of 0.1 mM. Bacterial cellsserological testing.
nnotation
utative lipoprotein e Prokaryotic homolog of protein DJ-1
utative exported protein e Tol/pal system protein
utative lipoprotein
hage shock protein B
utative membrane protein e prophage associated
utative exported protein e type IV pili
utative secreted protein e Choloylglycine secreted homolog
utative secreted protein e T3SS
utative lipoprotein e Endopeptidase
ytolethal distending toxin subunit B homolog
ypothetical protein e Unknown function
utative Zinc-protease
Figure 1 Correlation of IgM measurements between selected Salmonella Typhi antigens. A representative selection of data
showing a correlation in IgM measurements in human plasma for the antigens encoded by STY4539, STY1703, STY1886, and the
Vi antigen. Histograms show the distribution of IgM levels by optical density to the highlighted S. Typhi antigen. The scatterplots
below the histograms plot the IgM measurements of the two antigens on a right angle to the histograms and describe the correlation
between antibody responses to two selected antigens. The numerals above the histograms depict the Spearman correlation coef-
ficient (rho) values of the mirrored scatterplot. All other correlations are shown in Fig. S1.
Typhoid fever diagnostics 107were harvested (5000  g at 4 C for 10 min) after 3 h of in-
cubation at 24 C.
For soluble proteins, bacterial pellets were resuspended
in 50 mM phosphate buffer (pH 8) containing 300 mM NaCl
and 10 mM imidazole. After sonication, cell debris and the
membrane fragment were pelleted by centrifugation at
16,000  g at 4 C for 30 min. Supernatants were filtered
through a 0.45 mm membrane before being rocked at 4 C
with nickel coated agarose beads (Ni-NTA, Invitrogen) for
2 h. Protein bound Ni-NTA beads were loaded into gravity
flow columns (Qiagen, Germany) and washed with 20 mM
imidazole in phosphate buffer. Proteins were eluted with
250 mM imidazole in phosphate buffer. For insoluble pro-
teins a denaturing protocol was performed by firstly incu-
bating the bacterial cells in an 8 M urea (pH 7.8) solution
containing 20 mM sodium phosphate and 500 mM NaCl. Pro-
teins were eluted with 4 M Urea (pH3) in a solutioncontaining 20 mM Sodium Phosphate buffer and 500 mM
NaCl. Proteins were renatured after purification in 50 mM
Sodium Phosphate solution and 500 mM NaCl.ELISAs using S. Typhi protein antigens
ELISAs to detect antigen specific IgM in human plasma
samples were performed as described previously with 12
purified protein antigens and S. Typhi Vi polysaccharide an-
tigen.24,25 Briefly, 96 well flat-bottom ELISA plates (Nunc
2404, Thermo Scientific) were coated overnight with
100 ml per well of the various antigens (final concentrations;
7 mg/ml of protein antigens and 1 mg/ml for the Vi antigen
in 50 mM Carbonate Bicarbonate buffer). Coated plates
were washed and blocked with 5% milk solution in PBS. Af-
ter 2 h of blocking, plates were washed and incubated with
Figure 2 IgM responses against Salmonella Typhi antigens in a Bangladeshi cohort of febrile patients and controls. Boxplots
showing IgM measurements (optical density) in plasma from afebrile controls (light gray), febrile patients with an infection other
than typhoid fever (medium gray), and confirmed typhoid patients (dark gray). Dark horizontal lines represent the mean IgM
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Figure 3 Assessing the sensitivity and specificity of IgM against Salmonella Typhi antigens for the diagnosis of typhoid fever.
Receiver operating characteristic (ROC) curves summarizing the antibody responses against antigen combinations for the diagnosis
of typhoid. The x-axis displays the false positivity rate (Specificity) and the y-axis displays true positive rate (Sensitivity). The per-
formance of two, three and four antigens are shown by the dashed, gray, and black lines, respectively. A) ROC curve produced
when the positive references are typhoid cases confirmed by blood culture and PCR amplification (nZ 32). B) ROC curve produced
when the positive references are typhoid cases confirmed by blood culture only (n Z 19).
Typhoid fever diagnostics 109100 ml (per well) of a 1:200 dilution of plasma at ambient
temperature for 2 h. Plates were washed again and incu-
bated with 100 ml per well of alkaline phosphatase-
conjugated anti-human IgM at ambient temperature for
1 h. The final ELISA plates were developed using p-Nitro-
phenyl phosphate (SigmaFAST N1891, SigmaeAldrich, UK)
substrate for 30 min at ambient temperature and the final
absorbance were read at dual wavelengths (405 nm and
490 nm) using an automated microplate reader (Biorad).
End point positive absorbance results were defined as opti-
cal densities (OD) greater than the absorbance obtained for
the blank control wells plus four times the standard devia-
tion. Three wells of culture S. Typhi positive plasma were
run as control for every 96-well plate for each antigen.
The results of each ELISA plate were accepted only if the
OD values of the controlled were within their range of their
known values plus/minus two standard deviations of the
blank wells.
Statistical analysis
A geometric mean optical density was calculated to sum-
marize the IgM response to the S. Typhi antigens in each
arm of validation group including the negative reference
population samples (healthy controls and other confirmed
febrile infections) and the positive reference population
(febrile patients with confirmed S. Typhi). The Wilcoxonmeasurement, with the box representing the 25th and 75th percen
are represented by dots. A) Boxplots of antibody responses again
STY1086, STY1372, STY1612, STY1522, STY1703, STY1767, STY3208
cally significant between the healthy controls and typhoid infection
exception of STY1522 (p < 0.05 Wilcoxon Rank sum). B) Boxplots of
mean antibody measurements are statistically significant between
infections and typhoid infections (p < 0.05 Wilcoxon Rank sum).signed-rank test was used to test the null hypothesis; no
difference in optical densities between the patient groups.
Spearman’s rho was used to investigate potential correla-
tions between IgM antibody responses against the various
antigens. Receiver operating characteristic (ROC) curves
were used to determine the optimal cut-off and the speci-
ficity and sensitivity of the various antigens. A performance
estimation of more than one antigen combination was eval-
uated using Support Vector Machine (SVM). All analyses
were performed with R software (version 3.3.1; R Founda-
tion for Statistical Computing). All confidence intervals
(CIs) are reported 2-sided at the 95% intervals; all other sig-
nificant testing were performed 2-sided with a significance
level of p < 0.05.Results
Acute IgM antibody responses against Salmonella
Typhi antigens
Of the 18 protein antigens we targeted to purify, we were
able to express and purify 12 (Table 1).
We firstly performed ELISAs independently employing
the purified protein antigens and the Vi polysaccharide to
detect IgM in the plasma of 40 healthy control subjects, 17
febrile individuals with a confirmed infection other thantiles, whiskers represent the 5th and 95th percentiles; outliers
st (from left to right and upper to lower) STY0452, STY0769,
, and STY4190. All mean antibody measurements were statisti-
s and between other infections and typhoid infections, with the
antibody responses against (in order) STY4539, STY1886, Vi. All
the healthy controls and typhoid infections and between other
110 N. Tran Vu Thieu et al.typhoid, and 32 individuals with either blood culture or PCR
(or both) confirmed typhoid infections (n Z 89 samples).
We measured detectable IgM against all twelve of the
purified S. Typhi proteins and the Vi polysaccharide in all of
the 89 samples subjected to ELISA. We compared the IgM ti-
ters from each of the antigens individually to assess the
performance of the antigens and to identify potential cor-
relations between the serological targets. We found that
early IgM responses against the majority of the novel S. Ty-
phi protein antigens, with the exception of STY1522
(rho < 0.7), were highly correlated with one other
(rho > 0.8). Notably, the IgM response to the protein anti-
gens correlated weakly with those directed against the Vi
polysaccharide (rho < 0.6) (Fig. 1 and Fig. S1).
The diagnostic potential of IgM against Salmonella
Typhi antigens
IgM against all twelve of the protein antigens and the Vi
polysaccharide was significantly elevated in the plasma of
the typhoid patients in comparison with the healthy
controls (p < 0.05) (Fig. 2). Furthermore, there was a sig-
nificant differentiation in the plasma IgM measurements be-
tween the typhoid patients and those with a febrile disease
with an alternative confirmed etiology with all antigens
with the exception of STY1522 (p < 0.05).
By assessing raw antibody measurements, we surmised
that the best performing antigens, with respect to differ-
entiating between the patient groups were STY4539,
STY1886, and Vi (Fig. 2). The mean IgM responses (OD
values) in the afebrile controls, the other confirmed infec-
tions and the typhoid infections were 0.29, 0.27, and 0.42
(against STY4539), 0.17, 0.18, and 0.25 (against STY1886),
and 0.22, 0.21, and 0.35 (against Vi), respectively. This
segregation between the patient groups was highly signifi-
cant, resulting in p-values of 0.0001 and 0.003 for IgM
against STY4539; <0.0001 and 0.004 for IgM against
STY1886; and 0.0001 and 0.0001 for IgM against Vi, between
healthy controls and typhoid infections and between other
febrile diseases and typhoid infections, respectively (Wil-
coxon signed-rank test).
Sensitivity and specificity of the serodiagnostic
antigens
To further assess the IgM responses against the various S.
Typhi antigens for the purposes of diagnostic testing we
calculated sensitivities and specificities using a validation
group incorporating two positive reference groups and a
negative reference group for additional statistical power.
The negative reference group (n Z 57) was the combina-
tion of data from the afebrile controls (n Z 40) and from
those with a confirmed diagnosis other than typhoid
(n Z 17 cases). The assay results were validated indepen-
dently with two sets of positive reference data; these
were a combination of blood culture confirmed S. Typhi
along with those with a positive PCR amplification result
for S. Typhi from blood (n Z 32), and the blood culture
confirmed S. Typhi patients only (n Z 19).
The IgM responses against each of the antigens gener-
ated a continuous data set that was used to generate ROCcurves to optimize the index cut-off value. The defined cut-
off values of the thirteen antigens corresponded with a
range of sensitivities ranging from 0.50 to 0.84 and
specificities between 0.58 and 0.84; areas under the ROC
curve (AUC) ranged from 0.7 to 0.85. When used alone none
of the antigens demonstrated a sensitivity or specificity
>0.8. As predicted, Vi, STY4359, and STY1886 were the
three antigens with the greatest serodiagnostic capacity in
discriminating typhoid cases from afebrile controls and
other infections. The sensitivities and specificities for
identifying typhoid patients by IgM titers were 0.68; 0.8
(Vi), 0.62; 0.82 (STY4539), and 0.62; 0.82 (STY1886),
respectively. Correspondingly, the AUCs were 0.84 (95%CI:
0.71, 0.96), 0.77 (95%CI: 0.61, 0.92), and 0.77 (95%CI: 0.62,
0.91).
We next employed SVM to identify combinations of two
or more antigens across all 13 antigens to increase overall
sensitivity and specificity. Using confirmed S. Typhi infec-
tion by blood culture or PCR as the positive reference
(nZ 32), we found 11 combinations of two to four antigens
that gave sensitivities from 0.81 to 0.84, specificities from
0.81 to 0.86, and AUCs from 0.87 to 0.87 (Fig. 3). We addi-
tionally identified 17 combinations of two to four antigens
when using the positive reference as culture confirmed S.
Typhi only (n Z 19), obtaining sensitivities from 0.84 to
0.89, specificities from 0.88 to 0.94, and AUCs from 0.859
to 0.912 (Fig. 3, Tables 2 and 3).
For the positive reference sets, IgM against Vi contrib-
uted to all of the combinations, while STY1703, STY1886,
and STY4539 were present in more than half of the
combinations. The remaining nine antigens contributed to
at least one combination that gave sensitivities and
specificities >0.8. These results demonstrated that, in the
majority of examples, a combination of up to four antigens
was directly associated with an increased performance of
the IgM serology. However, the best performing antigens for
the identification of typhoid patients by IgM were Vi in
combination with either STY1703 or STY1886 (Tables 2
and 3).Identifying typhoid cases in patients with
undiagnosed febrile disease
In this Bangladeshi cohort there were 226 patients with
febrile disease without laboratory confirmed etiology and
18 with clinically suspected typhoid that were negative by
blood culture and PCR amplification. We aimed to estimate
the proportion of patients in this population who may have
typhoid by applying the SVM cutoffs and combining the IgM
titers against two S. Typhi antigens. We performed two in-
dependent analyses; the first combined IgM titers against
STY1703 and Vi using a combination of culture confirmed
S. Typhi and positive PCR amplification for S. Typhi from
blood as the positive reference group (Fig. 4 and Table 3).
Using these criteria we found that 142/226 (59%) of the un-
diagnosed febrile patient group and 16/18 (88%) with clini-
cally suspected typhoid had IgM titers indicative of typhoid.
Using more stringent criteria (blood culture confirmed pa-
tients) as the positive reference and a combination of IgM
against Vi and STY1886 we found that 119/226 (52%) febrile
Table 3 The sensitivity and specificity of multiple antigens for typhoid diagnosis using blood culture positive patients only as
positive reference group (n Z 19).
Antigen combinations STY1886 & Vi STY4190 &
STY1886 & Vi
STY4539 & STY4190 &
STY1886 & Vi
Specificity 0.88 0.89 0.88
Sensitivity 0.84 0.84 0.89
Number with undiagnosed febrile disease
predicted to have typhoid (n Z 226)
119 (52%) 78 (34%) 71 (31%)
Number with clinically suspected typhoid
disease predicted to have typhoid (n Z 18)
15 (83%) 13 (72%) 13 (72%)
AUC (95%CI) 0.859
(0.746, 0.972)
0.891
(0.791, 0.991)
0.912
(0.81, 1.014)
Table 2 The sensitivity and specificity of multiple antigens for typhoid diagnosis using blood culture and PCR positive patients
as positive reference group (n Z 32).
Antigen combinations STY1703 & Vi STY4539 &
STY1703 & Vi
STY4539 & STY1703 &
STY1886 & Vi
Specificity 0.86 0.86 0.86
Sensitivity 0.81 0.84 0.84
Number with undiagnosed febrile disease
predicted to have typhoid (n Z 243)
135 (59%) 134 (59%) 134 (59%)
Number with clinically suspected typhoid
disease predicted to have typhoid (n Z 18)
16 (88%) 16 (88%) 16 (88%)
AUC (95%CI) 0.865
(0.782, 0.947)
0.863
(0.779, 0.947)
0.866
(0.783, 0.949)
Typhoid fever diagnostics 111cases and 15/18 (83%) clinically suspected typhoid, respec-
tively, had a profile indicative of typhoid (Fig. 4).
Discussion
Typhoid is caused by a human restricted pathogen that is
transmitted fecal-orally. Consequently, improving theFigure 4 Detecting febrile patients with an IgM profile indicative
febrile patients that have an IgM measurement indicative of typhoid
includes healthy controls and patients other with infections. The wh
PCR. The gray circles are febrile patients with an IgM profile indicat
defined as having a typhoid infection using the pre-defined IgM pr
typhoid cases confirmed by blood culture or PCR (n Z 32); the sel
the positive reference was defined as the typhoid cases confirmed b
was STY1886 and Vi.quality of drinking water supplies and education in better
hygiene practices are likely the most effective measures to
for typhoid elimination. However, these interventions
cannot be promptly realized in the endemic areas of Africa
and South Asia. Therefore, the short-term control of
typhoid is dependent on large vaccination programmes
and appropriate treatment, both of which, for differingof typhoid fever. Plots predicting the number of undiagnosed
fever. The black circles represent the negative controls, which
ite boxes represent typhoid cases confirmed by blood culture or
ive of not having typhoid fever, gray boxes are febrile patients
ofile. A) Plot where the positive reference was defined as the
ected antigen combination was STY1703 and Vi. B) Plot where
y blood culture only (nZ 19); the selected antigen combination
112 N. Tran Vu Thieu et al.reasons, rely on better case detection. The fact that there
is not currently a typhoid diagnostic assay with a high
degree of sensitivity or specificity limits disease burden
assessments,26,27 and may result in patients being misdiag-
nosed and receiving a sub-optimal therapy.28 Furthermore,
with the global increase in S. Typhi associated with reduced
susceptibility and resistance against the fluoroquinolones
and other antimicrobials,29,30 the demand for typhoid diag-
nostics are now greater than ever.31,32
There is a paucity of data arising from studies on humans
with typhoid that have measured the immunological
response to S. Typhi specific antigens.7 Studies that have
been performed have found significant interferon-g (IFN-
g) responses in cells stimulated with various antigens
including fimbriae and outer membrane proteins using poly-
morphonuclear cells from the blood of typhoid patients.33
Further, when whole blood from typhoid patients is stimu-
lated with S. Typhi lipopolysaccharide, TNFa release is
lower during active typhoid than after antimicrobial treat-
ment, indicating a short immune modulation effect, which
may be induced by the Vi polysaccharide.34 Antigen arrays
and other probing techniques have being used successfully
to interrogate the antibody repertoire during early in-
fection,22,35e37 and have detected antibody responses to
several novel, and potentially organism specific, antigens
that may be able to distinguish typhoid patients from con-
trols.22 Using this “screening data” we rationally selected
several S. Typhi protein antigens and aimed to investigate
if early immunological diagnostic signals could be detected
in the plasma of febrile patients.
Our study focused on a well-defined patient group from
Bangladesh, who were enrolled for the primary focus of
studying typhoid diagnostics. Whilst the patient numbers
with typhoid in this group were relatively modest, the
clinical and laboratory criteria for patients with febrile
disease were consistent and have been previously assessed
with commercial serological tests for typhoid.23 We noted
that the IgM response against the twelve purified S. Typhi
protein antigens were stable and well correlated; the IgM
responses in comparison to Vi correlated less consistently.
These data confirm our original antigen screening data
and suggest that these antigens are immunogenic and
induce an antibody response early in infection. Given the
poor performance of commercial RDTs,38,39 our data signify
that the early detection of IgM against more specific S. Ty-
phi protein antigens may be a more specific and sensitive
approach for developing a RDT for typhoid.
Indistinguishable clinical features and the lack of a
reliable gold standard test complicate typhoid diagnosis.
Here, the IgM response against all 12 antigens was signif-
icantly higher in typhoid patients than both afebrile
controls and patients with febrile diseases other than
typhoid. Furthermore, through inference from the AUC
under the ROC curve we were able to identify the best
three performing antigens, which were encoded by STY4539
(PilL) and STY1886 (CdtB) in combination with the Vi
polysaccharide. PilL is a putative exported protein and a
component of the type IV pili encoded adjacent to the
genes encoding Vi on SPI-7.40,41 The PilL protein is induced
following uptake by human derived macrophages,42 and the
type IV pili to which it is associated facilitates entry into
epithelial cells.43 CdtB, encoded by STY1886, is one ofthe two A sub-units of typhoid toxin, an AB type toxin.44
Typhoid toxin is a virulence-associated factor of S. Typhi,
which is thought to be associated with the early symptoms
of typhoid.45 We confirm that this component of typhoid
toxin is immunogenic and may be an important biomarker
of acute typhoid.22,46 Whilst these three virulence factors
(PilL, CdtB, and Vi) were not sufficient in themselves to pro-
duce a reproducibly high (>0.8) degree of sensitivity and
specificity for typhoid diagnosis, we gained additional po-
wer by combining data from >1 antigen using an SVM
model. The IgM responses against Vi in combination with
either PilL or CdtB were found to generate the highest de-
gree of sensitivity and specificity. Seemingly, a combination
of the differing IgM responses against polysaccharide and a
protein compensates for a lower affinity to one of the anti-
gens. Furthermore, we were able to estimate the propor-
tion of the population that may have typhoid by imposing
cut-offs from the typhoid confirmed patients onto the pop-
ulation with undiagnosed febrile diseases. These data did
not generate a precise cut-off, therefore, our data suggest
that typhoid diagnostics are not an exact science and our
data should be interpreted with caution. These methods
warrant further investigation in additional cohorts, but it
suggests a substantial burden of undiagnosed febrile dis-
ease is associated with S. Typhi in this setting.
This study has limitations. The sample size was relatively
small; we aimed to rectify this by including a subset of
patients that appear tohaveS. TyphiDNA in theirbloodstream
but were culture negative.47 Using this combination of
methods as a gold standardwewere able to increase thediag-
nostic power of the assays. A further limitation is that this
study was conducted in a single healthcare location over a
limited time period.Whilst our data provide some confidence
that these serological assays may be of utility for typhoid di-
agnostics, thesemethods should to be validated in additional
cohorts. However, there remains a challenge in identifying
typhoid patients that have a sterile blood culture; a combina-
tion of novel approaches, such as metabolomics and/or func-
tional genomics,17,21 in a febrile disease cohort may add
further insight into this important patient group.
In conclusion, we have investigated the serological
diagnostic potential of S. Typhi protein antigens and the
Vi polysaccharide in a group of patients with febrile dis-
eases in Bangladesh. Our novel data show that serology
may have some utility for typhoid diagnostics and a combi-
nation of antigens improves the diagnostic potential. Our
assays give high levels of sensitivity and specificity, but
require further assessment in differing patient populations.
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